| Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function R Hojs, S Bevc, R Ekart, M Gorenjak, L Puklavec Nephrology Dialysis Transplantation 21 (7), 1855-1862, 2006 | 307 | 2006 |
| Lipid management in patients with chronic kidney disease CJ Ferro, PB Mark, M Kanbay, P Sarafidis, GH Heine, P Rossignol, ... Nature Reviews Nephrology 14 (12), 727-749, 2018 | 210 | 2018 |
| SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by … P Sarafidis, CJ Ferro, E Morales, A Ortiz, J Malyszko, R Hojs, K Khazim, ... Nephrology Dialysis Transplantation 34 (2), 208-230, 2019 | 192 | 2019 |
| The agreement between auscultation and lung ultrasound in hemodialysis patients: the LUST study C Torino, L Gargani, R Sicari, K Letachowicz, R Ekart, D Fliser, A Covic, ... Clinical Journal of the American Society of Nephrology 11 (11), 2005-2011, 2016 | 191 | 2016 |
| Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease. R Hojs, S Bevc, R Ekart, M Gorenjak, L Puklavec Clinical nephrology 70 (1), 10-17, 2008 | 154 | 2008 |
| Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy N Vodošek Hojs, S Bevc, R Ekart, R Hojs Antioxidants 9 (10), 925, 2020 | 113 | 2020 |
| The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial C Loutradis, PA Sarafidis, R Ekart, C Papadopoulos, V Sachpekidis, ... Kidney international 95 (6), 1505-1513, 2019 | 94 | 2019 |
| Predictive value of carotid intima media thickness in hemodialysis patients R Ekart, R Hojs, T Hojs‐Fabjan, BP Balon Artificial organs 29 (8), 615-619, 2005 | 81 | 2005 |
| Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project L Gargani, R Sicari, M Raciti, L Serasini, M Passera, C Torino, ... Nephrology Dialysis Transplantation 31 (12), 1982-1988, 2016 | 75 | 2016 |
| Markers of inflammation and oxidative stress in the development and progression of renal disease in diabetic patients R Hojs, R Ekart, S Bevc, N Hojs Nephron 133 (3), 159-162, 2016 | 72 | 2016 |
| Biomarkers of renal disease and progression in patients with diabetes R Hojs, R Ekart, S Bevc, N Hojs Journal of Clinical Medicine 4 (5), 1010-1024, 2015 | 64 | 2015 |
| Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease S Bevc, R Hojs, R Ekart, M Završnik, M Gorenjak, L Puklavec Journal of Diabetes Research 2012 (1), 179849, 2012 | 64 | 2012 |
| A randomized multicenter trial on a lung ultrasound–guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk C Zoccali, C Torino, F Mallamaci, P Sarafidis, A Papagianni, R Ekart, ... Kidney international 100 (6), 1325-1333, 2021 | 61 | 2021 |
| Lung ultrasound–guided dry weight assessment and echocardiographic measures in hypertensive hemodialysis patients: a randomized controlled study C Loutradis, CE Papadopoulos, V Sachpekidis, R Ekart, B Krunic, ... American Journal of Kidney Diseases 75 (1), 11-20, 2020 | 61 | 2020 |
| Simple cystatin C formula compared to sophisticated CKD‐EPI formulas for estimation of glomerular filtration rate in the elderly S Bevc, R Hojs, R Ekart, M Gorenjak, L Puklavec Therapeutic Apheresis and Dialysis 15 (3), 261-268, 2011 | 61 | 2011 |
| Measurement of breath ammonia for detection of patients with chronic kidney disease S Bevc, E Mohorko, M Kolar, P Brglez, A Holobar, D Kniepeiss, ... Clinical nephrology 88 (7), 14, 2017 | 60 | 2017 |
| Hyperuricemia, the heart, and the kidneys–to treat or not to treat? T Petreski, R Ekart, R Hojs, S Bevc Renal failure 42 (1), 978-986, 2020 | 58 | 2020 |
| Serum cystatin C-based formulas for prediction of glomerular filtration rate in patients with chronic kidney disease R Hojs, S Bevc, R Ekart, M Gorenjak, L Puklavec Nephron Clinical practice 114 (2), c118-c126, 2010 | 56 | 2010 |
| Review on inflammation markers in chronic kidney disease T Petreski, N Piko, R Ekart, R Hojs, S Bevc Biomedicines 9 (2), 182, 2021 | 55 | 2021 |
| Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA … PA Sarafidis, F Mallamaci, C Loutradis, R Ekart, C Torino, A Karpetas, ... Nephrology Dialysis Transplantation 34 (9), 1542-1548, 2019 | 52 | 2019 |
